Search results
Results from the WOW.Com Content Network
Pap test. The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and ...
Although most notable for its use in the detection of cervical cancer in the Pap test or Pap smear, it is also used to stain non-gynecological specimen preparations from a variety of bodily secretions and from small needle biopsies of organs and tissues. [4] [5] Papanicolaou published three formulations of this stain in 1942, 1954, and 1960. [2]
Andromachi Papanikolaou. Andromachi " Mary " Mavrogeni Papanikolaou[note 1] (1890-13 October 1982) was a Greek laboratory technician and the wife of Georgios Papanikolaou, the Greek pathologist who independently invented the pap test. For 21 years, Mary Papanikolaou volunteered to have her cervix sampled and smeared by her husband to help with ...
Due to cost, pain, or other factors, many women avoid traditional Pap smears that test for HPV and cervical cancer—experts say these new self-collection tests could help close that gap.
PAP smears can help healthcare professionals identify unusual changes to the cervix or precancerous cells on the cervix. This can help a person receive appropriate treatment early, potentially ...
Cervical cancer screening is a medical screening test designed to identify risk of cervical cancer. Cervical screening may involve looking for viral DNA, and/or to identify abnormal, potentially precancerous cells within the cervix as well as cells that have progressed to early stages of cervical cancer. [1][2] One goal of cervical screening is ...
The US Preventive Services Task Force recommends screening for cervical cancer with cervical cytology– also known as a Pap test or Pap smear –every three years for women ages 21 to 29. For ...
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1][4][5] and 2014. [6] The name comes from the location (Bethesda, Maryland ...